Tepid response in Mysuru district on inaugural day Mysuru/Bengaluru: While the hilly district of Kodagu registered the highest vaccination percentage of 84 per cent, Dakshina Kannada has clocked the lowest percentage of 34 per cent on the first day of nationwide vaccine drive launched by Prime Minister Narendra Modi on Saturday. As against 21,658 persons…
PM clears Covaxin and Covishield vaccines Bengaluru: Karnataka received 7.95 lakh vials of Covishield vaccine this afternoon as the first instalment to launch vaccine drive from Jan. 16, said Health and Medical Education Minister Dr. K. Sudhakar. Talking to media persons here this morning, the Minister said that the State has been allotted 13.9 lakh…
Logistics ready in district to receive vaccine for launch from Jan. 16 Mysore/Mysuru: Mysuru district is all set to receive its first tranche of COVID-19 vaccine to launch vaccination drive from Jan. 16 as already announced by Prime Minister Narendra Modi last week. “We are getting 70,000 vials of Covishield vaccine for the district to…
Covishield, Covaxin approved The vaccines are 110 percent safe: Drug Controller General of India Both vaccines to be administered in two doses Can be stored in normal refrigerator New Delhi: It is indeed a red-letter day for India today as two vaccines for COVID-19 produced by Pune-based Serum Institute’s Covishield and Bharat Biotech’s Covaxin, received…
Serum Institute seeks Emergency Use Authorisation for COVID-19 vaccine Clinical trials were conducted at JSS Medical College in Mysuru in August New Delhi: The Serum Institute of India (SII) yesterday became the country’s first company to apply to the Drugs Controller General of India (DCGI) seeking Emergency Use Authorisation (EUA) for the Oxford COVID-19 vaccine…
Mysore/Mysuru: The clinical trial of COVID-19 vaccine — Covishield — developed by the University of Oxford and manufactured at the Pune-based Serum Institute of India (SII), which began at JSS Hospital here in August, has completed the Phase II and the analysing process is going on. Five volunteers, who had enrolled for the Phase II…
Mysuru District Hospital begins to issue COVID Death Certificates Mysore/Mysuru: The much-awaited clinical trial of COVID-19 vaccine – Covishield – developed by the University of Oxford began at JSS Hospital in city this morning. Pune-based Serum Institute of India partnered with AstraZeneca to manufacture the COVID-19 vaccine candidate. The volunteers received their first doses intramuscularly…
Mysore/Mysuru: The Phase-2 human trials of Oxford University’s COVID-19 vaccine ‘Covishield’, manufactured at the Pune-based Serum Institute of India (SII) will begin at Mysuru’s JSS Hospital and Medical College in a couple of days. The Institute is awaiting guidelines and samples from SII. The JSS Hospital has been shortlisted to take up the COVID-19 vaccine…
Clinical trial to evaluate if Covishield vaccine can prevent symptomatic Coronavirus Disease 2019 (COVID-19) Mysore/Mysuru: Mysuru’s JSS Hospital and Medical College has been shortlisted by Indian Council of Medical Research (ICMR) for Serum Institute of India’s COVID-19 vaccine candidate — Covishield — trial. The clinical trial is designed to evaluate if an investigational vaccine can…
City under security cover for voting dayApril 24, 2024
1,477 cVIGIL app plaints filed in Mysuru; act...April 24, 2024
Poll Officers must report to Mustering Centre...April 24, 2024
Leaders make last-minute pitch as public camp...April 24, 2024
Recent Comments